中(zhong)證網訊（記者 康曦）科(ke)倫藥業(ye)（002422）4月14日晚間披(pi)露一季度業(ye)績預告。公(gong)司(si)預計(ji)1-3月實(shi)現歸屬于(yu)上(shang)(shang)市公(gong)司(si)股(gu)東(dong)的凈利潤0萬(wan)元-3356.88萬(wan)元，同(tong)比(bi)下降90%-100%。公(gong)告稱，受(shou)新型冠(guan)狀病(bing)毒(du)疫情影響，醫療(liao)機構非疫情科(ke)室(shi)未(wei)正常(chang)開展診療(liao)工作，導致公(gong)司(si)輸(shu)液產(chan)品銷量較上(shang)(shang)年(nian)同(tong)期(qi)大幅下降；伊犁川寧工藝持(chi)續(xu)優化(hua)及產(chan)能(neng)充分釋放(fang)，使得(de)產(chan)品生產(chan)成本持(chi)續(xu)下降，產(chan)品價格受(shou)市場環境影響，恢復性(xing)上(shang)(shang)漲，但(dan)尚未(wei)回升至去年(nian)同(tong)期(qi)水平，造成利潤同(tong)比(bi)下降；公(gong)司(si)持(chi)續(xu)大力推進“創新驅動(dong)”，研(yan)發(fa)費用較去年(nian)同(tong)期(qi)增(zeng)加；此(ci)外，受(shou)匯率波動(dong)影響，子公(gong)司(si)科(ke)倫KAZ藥業(ye)有限責(ze)任公(gong)司(si)因其貨幣貶值，造成匯兌損失增(zeng)加。